Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Richard Leggett, DO

Crossroads Clinical Research

Disclosure(s): Crossroads Clinical Research: Contract employee

Poster(s):

112 - Interim Results From a Phase 2, Randomized, Observer-Blind, Placebo-Controlled, Dose-Finding Trial of an mRNA-Based Cytomegalovirus Vaccine in Healthy Adults
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET